Literature DB >> 23299999

Differential expression of intracellular and extracellular CB(2) cannabinoid receptor protein by human peripheral blood leukocytes.

Julie T Castaneda1, Airi Harui, Sylvia M Kiertscher, Jeffrey D Roth, Michael D Roth.   

Abstract

mRNA encoding for the CB(2) cannabinoid receptor is expressed by many subsets of human peripheral blood leukocytes (PBL), but little is known about the resulting protein expression and function. Employing clones from the A549 and 293T cell lines that were constructed to express both full-length human CB(2) and GFP, we developed a flow cytometry assay for characterizing CB(2) protein expression. A monoclonal antibody directed against human CB(2) selectively stained the surface of transduced but not parental cell lines. When cells were fixed and permeabilized, imaging flow cytometry identified large stores of intracellular protein. Total cellular staining for CB(2) corresponded closely with the level of GFP expression. When exposed to Δ(9)-tetrahydrocannabinol, CB(2)-expressing cells internalized cell surface CB(2) receptors in a time- and dose-dependent manner. Applying these approaches to human PBL, CB(2) protein was identified on the surface of human B cells but not on T cells or monocytes. In contrast, when PBL were fixed and permeabilized, intracellular CB(2) expression was readily detected in all three subsets by both conventional and imaging flow cytometry. Similar to the protein expression pattern observed in fixed and permeabilized PBL, purified B cells, T cells, and monocytes expressed relatively equal levels of CB(2) mRNA by quantitative real-time RT-PCR. Our findings confirm that human PBL express CB(2) protein but that its distribution is predominantly intracellular with only B cells expressing CB(2) protein at the extracellular membrane. The differential role of intracellular and extracellular CB(2) receptors in mediating ligand signaling and immune function remains to be determined.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23299999      PMCID: PMC3587044          DOI: 10.1007/s11481-012-9430-8

Source DB:  PubMed          Journal:  J Neuroimmune Pharmacol        ISSN: 1557-1890            Impact factor:   4.147


  38 in total

1.  Modulation and functional involvement of CB2 peripheral cannabinoid receptors during B-cell differentiation.

Authors:  P Carayon; J Marchand; D Dussossoy; J M Derocq; O Jbilo; A Bord; M Bouaboula; S Galiègue; P Mondière; G Pénarier; G L Fur; T Defrance; P Casellas
Journal:  Blood       Date:  1998-11-15       Impact factor: 22.113

2.  Intracellular cannabinoid type 1 (CB1) receptors are activated by anandamide.

Authors:  G Cristina Brailoiu; Tudor I Oprea; Pingwei Zhao; Mary E Abood; Eugen Brailoiu
Journal:  J Biol Chem       Date:  2011-06-30       Impact factor: 5.157

3.  Molecular cloning, expression and function of the murine CB2 peripheral cannabinoid receptor.

Authors:  D Shire; B Calandra; M Rinaldi-Carmona; D Oustric; B Pessègue; O Bonnin-Cabanne; G Le Fur; D Caput; P Ferrara
Journal:  Biochim Biophys Acta       Date:  1996-06-07

4.  Impairment of antimicrobial activity and nitric oxide production in alveolar macrophages from smokers of marijuana and cocaine.

Authors:  Angela Hanchi Shay; Ruth Choi; Katherine Whittaker; Ken Salehi; Christina M R Kitchen; Donald P Tashkin; Michael D Roth; Gayle Cocita Baldwin
Journal:  J Infect Dis       Date:  2003-02-07       Impact factor: 5.226

5.  Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.

Authors:  A R Schatz; M Lee; R B Condie; J T Pulaski; N E Kaminski
Journal:  Toxicol Appl Pharmacol       Date:  1997-02       Impact factor: 4.219

6.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

7.  Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation.

Authors:  Yoonkyung Do; Robert J McKallip; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

8.  Delta(9)-tetrahydrocannabinol-induced apoptosis in the thymus and spleen as a mechanism of immunosuppression in vitro and in vivo.

Authors:  Robert J McKallip; Catherine Lombard; Billy R Martin; Mitzi Nagarkatti; Prakash S Nagarkatti
Journal:  J Pharmacol Exp Ther       Date:  2002-08       Impact factor: 4.030

9.  Cannabinoid-receptor expression in human leukocytes.

Authors:  M Bouaboula; M Rinaldi; P Carayon; C Carillon; B Delpech; D Shire; G Le Fur; P Casellas
Journal:  Eur J Biochem       Date:  1993-05-15

10.  Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors.

Authors:  Maria Teresa Cencioni; Valerio Chiurchiù; Giuseppina Catanzaro; Giovanna Borsellino; Giorgio Bernardi; Luca Battistini; Mauro Maccarrone
Journal:  PLoS One       Date:  2010-01-14       Impact factor: 3.240

View more
  21 in total

Review 1.  Effects of Cannabinoids on T-cell Function and Resistance to Infection.

Authors:  Toby K Eisenstein; Joseph J Meissler
Journal:  J Neuroimmune Pharmacol       Date:  2015-04-16       Impact factor: 4.147

2.  Δ(9)-Tetrahydrocannabinol treatment during human monocyte differentiation reduces macrophage susceptibility to HIV-1 infection.

Authors:  Julie C Williams; Sofia Appelberg; Bruce A Goldberger; Thomas W Klein; John W Sleasman; Maureen M Goodenow
Journal:  J Neuroimmune Pharmacol       Date:  2014-02-23       Impact factor: 4.147

3.  Targeted zwitterionic near infrared fluorescent probe for improved imaging of type 2 cannabinoid receptors.

Authors:  Zhiyuan Wu; Pin Shao; Shaojuan Zhang; Mingfeng Bai
Journal:  J Biomed Opt       Date:  2014-03       Impact factor: 3.170

4.  Regulation of Cell Surface CB2 Receptor during Human B Cell Activation and Differentiation.

Authors:  Julie T Castaneda; Airi Harui; Michael D Roth
Journal:  J Neuroimmune Pharmacol       Date:  2017-03-31       Impact factor: 4.147

5.  Endocannabinoids produced upon action potential firing evoke a Cl(-) current via type-2 cannabinoid receptors in the medial prefrontal cortex.

Authors:  Femke S den Boon; Pascal Chameau; Kas Houthuijs; Simone Bolijn; Nicolina Mastrangelo; Chris G Kruse; Mauro Maccarrone; Wytse J Wadman; Taco R Werkman
Journal:  Pflugers Arch       Date:  2014-03-28       Impact factor: 3.657

6.  In vivo inflammation imaging using a CB2R-targeted near infrared fluorescent probe.

Authors:  Shaojuan Zhang; Pin Shao; Xiaoxi Ling; Ling Yang; Weizhou Hou; Steve H Thorne; Wissam Beaino; Carolyn J Anderson; Ying Ding; Mingfeng Bai
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-02-15

7.  Exposure to Δ9-Tetrahydrocannabinol Impairs the Differentiation of Human Monocyte-derived Dendritic Cells and their Capacity for T cell Activation.

Authors:  Michael D Roth; Julie T Castaneda; Sylvia M Kiertscher
Journal:  J Neuroimmune Pharmacol       Date:  2015-01-23       Impact factor: 4.147

8.  Target-selective phototherapy using a ligand-based photosensitizer for type 2 cannabinoid receptor.

Authors:  Shaojuan Zhang; Ningyang Jia; Pin Shao; Qin Tong; Xiang-Qun Xie; Mingfeng Bai
Journal:  Chem Biol       Date:  2014-02-27

9.  Co-expression of γ2 subunits hinders processing of N-linked glycans attached to the N104 glycosylation sites of GABAA receptor β2 subunits.

Authors:  Wen-Yi Lo; Andre H Lagrange; Ciria C Hernandez; Katharine N Gurba; Robert L Macdonald
Journal:  Neurochem Res       Date:  2013-11-12       Impact factor: 3.996

10.  A Prospective Study of Humoral and Cellular Immune Responses to Hepatitis B Vaccination in Habitual Marijuana Smokers.

Authors:  Sylvia M Kiertscher; Pallavi R Gangalum; Grace Ibrahim; Donald P Tashkin; Michael D Roth
Journal:  J Neuroimmune Pharmacol       Date:  2018-01-16       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.